BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6361563)

  • 1. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract.
    Crystal RG; Bitterman PB; Rennard SI; Hance AJ; Keogh BA
    N Engl J Med; 1984 Jan; 310(4):235-44. PubMed ID: 6361563
    [No Abstract]   [Full Text] [Related]  

  • 2. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts).
    Crystal RG; Bitterman PB; Rennard SI; Hance AJ; Keogh BA
    N Engl J Med; 1984 Jan; 310(3):154-66. PubMed ID: 6361560
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interstitial lung diseases. I. Pathomorphological and immunological aspects and the methods of studies].
    Hajduk B; Małecka G; Derentowicz P; Roszkowski W
    Pneumonol Pol; 1990; 58(4-5):263-8. PubMed ID: 2144046
    [No Abstract]   [Full Text] [Related]  

  • 4. Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis.
    Hance AJ; Basset F; Saumon G; Danel C; Valeyre D; Battesti JP; Chrétien J; Georges R
    Ann N Y Acad Sci; 1986; 465():643-56. PubMed ID: 3488004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological aspects of chronic non-infectious pulmonary diseases of the lower respiratory tract in man.
    Hunninghake GW; Gadek JE
    Clin Immunol Rev; 1981-1982; 1(3):337-74. PubMed ID: 6762278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Langerhans' cells in patients with fibrotic lung disorders.
    Kawanami O; Basset F; Ferrans VJ; Soler P; Crystal RG
    Lab Invest; 1981 Mar; 44(3):227-33. PubMed ID: 6970300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary biopsy in interstitial pneumopathies].
    Kuffer T; Kapanci Y
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1908-11. PubMed ID: 6977183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.
    Venet A; Hance AJ; Saltini C; Robinson BW; Crystal RG
    J Clin Invest; 1985 Jan; 75(1):293-301. PubMed ID: 3871200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bronchoalveolar lavage cytology in interstitial pathology].
    Amouroux J
    Arch Anat Cytol Pathol; 1986; 34(1):17-9. PubMed ID: 3488033
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diffuse interstitial pulmonary fibrosis. Current etiopathogenetic and diagnostic aspects].
    Bariffi F; Marsico SA; Pesci A; Marangio E; Trańfa C
    Recenti Prog Med; 1984 Dec; 75(12):1097-155. PubMed ID: 6396750
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bronchoalveolar lavage in diffuse interstitial lung diseases].
    Music E; Mermolja M; Debeljak A; Sorli J
    Plucne Bolesti; 1984; 36(1-2):69-72. PubMed ID: 6514849
    [No Abstract]   [Full Text] [Related]  

  • 12. Peroxidatic activities of human alveolar macrophages in some pulmonary granulomatous disorders.
    Soler P; Basset F; Mazin F; Grandsaigne M; Breton-Gorius J
    J Reticuloendothel Soc; 1982 Jun; 31(6):511-21. PubMed ID: 6981700
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of immunologic analysis of bronchoalveolar lavage fluid in the study of interstitial pulmonary fibrosis (review of the literature)].
    Belokrinitskiĭ DV; Kudriavitskiĭ AI; Kornev BM
    Lab Delo; 1984; (2):67-75. PubMed ID: 6200661
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis of pulmonary histiocytosis X by immunodetection of Langerhans cells in bronchoalveolar lavage fluid.
    Chollet S; Soler P; Dournovo P; Richard MS; Ferrans VJ; Basset F
    Am J Pathol; 1984 May; 115(2):225-32. PubMed ID: 6372496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cellular composition and T-lymphocyte subpopulations in the bronchoalveolar lavage fluid in patients with fibrosing alveolitis and pulmonary granulomatosis].
    Orlova GP; Zhuravlev AV
    Klin Med (Mosk); 1990 Jan; 68(1):69-73. PubMed ID: 2335926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenetic mechanisms in immunologic lung disease.
    Reynolds HY
    Hosp Pract (Off Ed); 1986 Apr; 21(4):91-9, 103-8. PubMed ID: 2937797
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value and indications for bronchoalveolar lavage combined with transbronchial lung biopsy].
    Popper H; Pongratz M
    Wien Klin Wochenschr; 1987 Dec; 99(24):848-55. PubMed ID: 3439184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders.
    Bitterman PB; Adelberg S; Crystal RG
    J Clin Invest; 1983 Nov; 72(5):1801-13. PubMed ID: 6630527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymphocyte populations in bronchoalveolar lavage fluid in various interstitial lung diseases].
    Müller S; Kramer H; Bergmann KC; Wiesner B; Grollmuss H; Unger U; Christ R; Eckert H
    Z Erkr Atmungsorgane; 1984; 163(2):140-5. PubMed ID: 6506803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of most important clinico-immunologic indicators in differential diagnosis of sarcoidosis and histiocytosis X of the lungs].
    Orlova GP; Kolesin ID
    Klin Med (Mosk); 1989 Sep; 67(9):41-4. PubMed ID: 2586039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.